Literature DB >> 16570340

Hepatobiliary and pancreatic disorders in celiac disease.

Hugh James Freeman.   

Abstract

A variety of hepatic and biliary tract disorders may complicate the clinical course of celiac disease. Some of these have been hypothesized to share common genetic factors or have a common immunopathogenesis, such as primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune forms of hepatitis or cholangitis. Other hepatic changes in celiac disease may be associated with malnutrition resulting from impaired nutrient absorption, including hepatic steatosis. In addition, celiac disease may be associated with rare hepatic complications, such as hepatic T-cell lymphoma. Finally, pancreatic exocrine function may be impaired in celiac disease and represent a cause of treatment failure.

Entities:  

Mesh:

Year:  2006        PMID: 16570340      PMCID: PMC4124280          DOI: 10.3748/wjg.v12.i10.1503

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  82 in total

1.  Adult celiac disease and hemochromatosis.

Authors:  A Turcu; L Lévêque; P Bielefeld; J F Besancenot; P Hillon
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease.

Authors:  M A Heneghan; K M Feeley; F M Stevens; M P Little; C F McCarthy
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.

Authors:  Katri Kaukinen; Leena Halme; Pekka Collin; Martti Färkkilä; Markku Mäki; Paula Vehmanen; Jukka Partanen; Krister Höckerstedt
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy.

Authors:  A Floreani; C Betterle; A Baragiotta; S Martini; C Venturi; D Basso; M Pittoni; S Chiarelli; C Sategna Guidetti
Journal:  Dig Liver Dis       Date:  2002-04       Impact factor: 4.088

5.  Celiac disease in autoimmune cholestatic liver disorders.

Authors:  Umberto Volta; Luis Rodrigo; Alessandro Granito; Nunzio Petrolini; Paolo Muratori; Luigi Muratori; Antonio Linares; Lorenza Veronesi; Dolores Fuentes; Daniela Zauli; Francesco B Bianchi
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

6.  Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis.

Authors:  H R Gillett; K Cauch-Dudek; E Jenny; E J Heathcote; H J Freeman
Journal:  Can J Gastroenterol       Date:  2000-09       Impact factor: 3.522

7.  High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.

Authors:  P M Gillett; H R Gillett; D M Israel; D L Metzger; L Stewart; J P Chanoine; H J Freeman
Journal:  Can J Gastroenterol       Date:  2001-05       Impact factor: 3.522

Review 8.  Coeliac disease.

Authors:  Hugh Freeman; Michel Lemoyne; Pierre Pare
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-02       Impact factor: 3.043

9.  The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.

Authors:  Jeffrey R Butterworth; Brian T Cooper; William M C Rosenberg; Michael Purkiss; Shirley Jobson; Mark Hathaway; David Briggs; W Martin Howell; Gordon M Wood; David H Adams; Tariq H Iqbal
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

10.  Celiac disease-associated autoimmune cholangitis.

Authors:  Robert E Sedlack; Thomas C Smyrk; Albert J Czaja; Jayant A Talwalkar
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

View more
  13 in total

1.  Reproductive changes associated with celiac disease.

Authors:  Hugh-James Freeman
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

2.  Adult celiac disease in the elderly.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

3.  Immunological comorbity in coeliac disease: associations, risk factors and clinical implications.

Authors:  Luca Elli; Antonella Bonura; Daniela Garavaglia; Eliana Rulli; Irene Floriani; Giovanna Tagliabue; Paolo Contiero; Maria Teresa Bardella
Journal:  J Clin Immunol       Date:  2012-04-19       Impact factor: 8.317

Review 4.  Pathogenesis and clinical significance of liver injury in celiac disease.

Authors:  Umberto Volta
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

5.  Spontaneous gallbladder pathology in baboons.

Authors:  J L Slingluff; J T Williams; L Blau; A Blau; E J Dick; G B Hubbard
Journal:  J Med Primatol       Date:  2009-09-28       Impact factor: 0.667

6.  Hepatobiliary disorders in celiac disease: an update.

Authors:  Kaushal K Prasad; Uma Debi; Saroj K Sinha; Chander K Nain; Kartar Singh
Journal:  Int J Hepatol       Date:  2010-11-14

7.  Liver complications in celiac disease.

Authors:  Mohammad Reza Zali; Mohammad Rostami Nejad; Kamran Rostami; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2011-05       Impact factor: 0.660

8.  Hepatic hemangioma in celiac patients: data from a large consecutive series.

Authors:  Sara Massironi; Federica Branchi; Roberta Elisa Rossi; Mirella Fraquelli; Luca Elli; Maria Teresa Bardella; Federica Cavalcoli; Dario Conte
Journal:  Gastroenterol Res Pract       Date:  2015-01-12       Impact factor: 2.260

9.  The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease.

Authors:  Mostafa Alavi Moghaddam; Mohammad Rostami Nejad; Hamid Mohaghegh Shalmani; Kamran Rostami; Ehsan Nazemalhosseini Mojarad; David Aldulaimi; Mohammad Reza Zali
Journal:  Int J Prev Med       Date:  2013-06

Review 10.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.